| Released | Contributor | Author | Title | Pages | Price |
|---|
| May 19, 2013 | New Constructs, LLC | N/A | DVAX: Due Diligence Review: Forensic Earnings and Valuation | 13 | $25 | | May 19, 2013 | ValuEngine, Inc. | N/A | ValuEngine Industry Report for Medical-biomed/genetics | 18 | $207 | | May 18, 2013 | Wright Reports | N/A | Wright Investors Service Comprehensive Report for Dynavax Technologies Corporation | 41 | $471.50 | | May 17, 2013 | Pechala's Reports | Frantisek Pechala | DYNAVAX TECHNOLOGIES CP (DVAX) 12-months forecast | 1 | $15 | | May 16, 2013 | Ford Investor Services, Inc. | N/A | Industry Value Graph: ALNY , CRTX , DVAX , IBIO , PTN , SGEN , SNMX -- DRUGS | 3 | $34.50 | | May 16, 2013 | Ford Investor Services, Inc. | N/A | Value Graph: DYNAVAX TECHNOL -- DVAX | 1 | $11.50 | | May 15, 2013 | ValuEngine, Inc. | N/A | ValuEngine Detailed Valuation Report for DVAX | 11 | $126.50 | | May 11, 2013 | TheStreet.com Ratings | N/A | TheStreet.com Ratings Stock Report For: DYNAVAX TECHNOLOGIES CORP | 5 | $10 | | May 10, 2013 | S&P Capital IQ Quantitative Report | N/A | Dynavax Technologies | 6 | $69 | | May 9, 2013 | Zacks Investment Research Inc. | N/A | DYNAVAX TECH CP (DVAX) Zacks Company Snapshot | 1 | $11.50 |
|
View All Reports for DVAX ... |
|
|
0.16%